Annual FCF
-$6.21 M
+$283.00 K+4.36%
31 October 2023
Summary:
Anixa Biosciences annual free cash flow is currently -$6.21 million, with the most recent change of +$283.00 thousand (+4.36%) on 31 October 2023. During the last 3 years, it has fallen by -$1.27 million (-25.74%). ANIX annual FCF is now -574.48% below its all-time high of $1.31 million, reached on 31 October 2015.ANIX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$2.64 M
-$1.19 M-81.52%
01 July 2024
Summary:
Anixa Biosciences quarterly free cash flow is currently -$2.64 million, with the most recent change of -$1.19 million (-81.52%) on 01 July 2024. Over the past year, it has dropped by -$674.00 thousand (-34.23%). ANIX quarterly FCF is now -157.48% below its all-time high of $4.60 million, reached on 31 January 2015.ANIX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$8.38 M
-$1.20 M-16.69%
01 July 2024
Summary:
Anixa Biosciences TTM free cash flow is currently -$8.38 million, with the most recent change of -$1.20 million (-16.69%) on 01 July 2024. Over the past year, it has dropped by -$2.17 million (-34.92%). ANIX TTM FCF is now -347.03% below its all-time high of $3.39 million, reached on 31 January 2015.ANIX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -34.2% | -34.9% |
| 3 y3 years | -25.7% | -152.9% | -69.6% |
| 5 y5 years | -26.3% | -97.7% | -70.4% |
ANIX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.7% | +4.4% | -227.5% | at low | -69.6% | at low |
| 5 y | 5 years | -26.3% | +4.4% | -227.5% | at low | -70.4% | at low |
| alltime | all time | -574.5% | +41.4% | -157.5% | +5.6% | -347.0% | +21.0% |
Anixa Biosciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | -$2.64 M(+81.5%) | -$8.38 M(+16.7%) |
| Apr 2024 | - | -$1.46 M(-36.9%) | -$7.18 M(+9.9%) |
| Jan 2024 | - | -$2.31 M(+17.3%) | -$6.53 M(+5.2%) |
| Oct 2023 | -$6.21 M(-4.4%) | -$1.97 M(+36.3%) | -$6.21 M(+6.4%) |
| July 2023 | - | -$1.45 M(+79.1%) | -$5.83 M(+0.8%) |
| Apr 2023 | - | -$807.00 K(-59.4%) | -$5.78 M(-20.6%) |
| Jan 2023 | - | -$1.99 M(+24.8%) | -$7.28 M(+12.2%) |
| Oct 2022 | -$6.49 M(+31.5%) | -$1.59 M(+14.1%) | -$6.49 M(+9.2%) |
| July 2022 | - | -$1.40 M(-39.5%) | -$5.94 M(-1.4%) |
| Apr 2022 | - | -$2.31 M(+92.6%) | -$6.03 M(+21.4%) |
| Jan 2022 | - | -$1.20 M(+14.5%) | -$4.96 M(+0.5%) |
| Oct 2021 | -$4.94 M(-20.2%) | -$1.04 M(-29.4%) | -$4.94 M(-7.0%) |
| July 2021 | - | -$1.48 M(+19.2%) | -$5.31 M(+3.7%) |
| Apr 2021 | - | -$1.24 M(+6.2%) | -$5.12 M(-5.8%) |
| Jan 2021 | - | -$1.17 M(-17.3%) | -$5.43 M(-12.3%) |
| Oct 2020 | -$6.19 M(+25.9%) | -$1.41 M(+9.5%) | -$6.19 M(+1.3%) |
| July 2020 | - | -$1.29 M(-17.0%) | -$6.11 M(+11.9%) |
| Apr 2020 | - | -$1.56 M(-19.4%) | -$5.46 M(-1.0%) |
| Jan 2020 | - | -$1.93 M(+44.4%) | -$5.52 M(+12.2%) |
| Oct 2019 | -$4.92 M(+14.0%) | -$1.34 M(+108.9%) | -$4.92 M(+6.7%) |
| July 2019 | - | -$640.10 K(-60.2%) | -$4.61 M(-10.7%) |
| Apr 2019 | - | -$1.61 M(+21.1%) | -$5.16 M(+20.0%) |
| Jan 2019 | - | -$1.33 M(+29.4%) | -$4.30 M(-0.3%) |
| Oct 2018 | -$4.31 M(+12.7%) | -$1.03 M(-13.7%) | -$4.31 M(+6.8%) |
| July 2018 | - | -$1.19 M(+58.3%) | -$4.04 M(-1.6%) |
| Apr 2018 | - | -$751.80 K(-44.0%) | -$4.10 M(-7.3%) |
| Jan 2018 | - | -$1.34 M(+78.4%) | -$4.43 M(+15.6%) |
| Oct 2017 | -$3.83 M(+8.5%) | -$752.60 K(-40.0%) | -$3.83 M(+1.8%) |
| July 2017 | - | -$1.25 M(+16.5%) | -$3.76 M(+13.1%) |
| Apr 2017 | - | -$1.08 M(+44.7%) | -$3.32 M(-8.5%) |
| Jan 2017 | - | -$744.00 K(+8.6%) | -$3.63 M(+3.0%) |
| Oct 2016 | -$3.53 M(-369.6%) | -$684.90 K(-16.3%) | -$3.53 M(-3.2%) |
| July 2016 | - | -$818.20 K(-41.0%) | -$3.65 M(+3.1%) |
| Apr 2016 | - | -$1.39 M(+117.2%) | -$3.54 M(-10.0%) |
| Jan 2016 | - | -$638.40 K(-20.4%) | -$3.93 M(-400.2%) |
| Oct 2015 | $1.31 M(-154.8%) | -$801.90 K(+13.2%) | $1.31 M(-25.2%) |
| July 2015 | - | -$708.50 K(-60.2%) | $1.75 M(-17.5%) |
| Apr 2015 | - | -$1.78 M(-138.7%) | $2.12 M(-37.5%) |
| Jan 2015 | - | $4.60 M(-1369.9%) | $3.39 M(-242.5%) |
| Oct 2014 | -$2.39 M(-25.1%) | -$362.10 K(+7.4%) | -$2.38 M(-7.1%) |
| July 2014 | - | -$337.30 K(-33.6%) | -$2.56 M(-16.4%) |
| Apr 2014 | - | -$507.80 K(-56.7%) | -$3.06 M(-11.7%) |
| Jan 2014 | - | -$1.17 M(+115.3%) | -$3.47 M(+8.8%) |
| Oct 2013 | -$3.19 M(+1.5%) | -$544.40 K(-35.2%) | -$3.19 M(-11.6%) |
| July 2013 | - | -$839.70 K(-8.0%) | -$3.60 M(+6.2%) |
| Apr 2013 | - | -$912.70 K(+2.6%) | -$3.39 M(+0.6%) |
| Jan 2013 | - | -$890.00 K(-7.4%) | -$3.37 M(+7.4%) |
| Oct 2012 | -$3.14 M(+333.2%) | -$960.80 K(+52.9%) | -$3.14 M(+8.6%) |
| July 2012 | - | -$628.40 K(-29.7%) | -$2.89 M(+210.2%) |
| Apr 2012 | - | -$893.40 K(+35.8%) | -$932.40 K(+21.5%) |
| Jan 2012 | - | -$658.10 K(-7.6%) | -$767.30 K(+5.8%) |
| Oct 2011 | -$725.00 K(-69.9%) | -$712.50 K(-153.5%) | -$725.10 K(+36.9%) |
| July 2011 | - | $1.33 M(-282.8%) | -$529.70 K(-78.7%) |
| Apr 2011 | - | -$728.30 K(+18.2%) | -$2.49 M(+12.8%) |
| Jan 2011 | - | -$615.90 K(+19.1%) | -$2.21 M(-8.2%) |
| Oct 2010 | -$2.41 M(-3.8%) | -$517.10 K(-17.8%) | -$2.41 M(-0.2%) |
| July 2010 | - | -$629.10 K(+41.1%) | -$2.41 M(+2.7%) |
| Apr 2010 | - | -$445.70 K(-45.2%) | -$2.35 M(-11.7%) |
| Jan 2010 | - | -$813.80 K(+55.7%) | -$2.66 M(+6.2%) |
| Oct 2009 | -$2.50 M(+173.4%) | -$522.70 K(-7.6%) | -$2.50 M(-4.4%) |
| July 2009 | - | -$565.70 K(-25.3%) | -$2.62 M(+240.8%) |
| Apr 2009 | - | -$757.80 K(+15.3%) | -$768.00 K(+4.9%) |
| Jan 2009 | - | -$657.40 K(+3.3%) | -$732.10 K(-20.1%) |
| Oct 2008 | -$915.70 K(-62.0%) | -$636.70 K(-149.6%) | -$915.80 K(+12.4%) |
| July 2008 | - | $1.28 M(-277.9%) | -$815.10 K(-69.2%) |
| Apr 2008 | - | -$721.90 K(-14.2%) | -$2.64 M(+8.0%) |
| Jan 2008 | - | -$841.10 K(+56.9%) | -$2.45 M(+1.5%) |
| Oct 2007 | -$2.41 M | -$536.00 K(-1.4%) | -$2.41 M(+8.3%) |
| July 2007 | - | -$543.60 K(+3.2%) | -$2.23 M(+3.2%) |
| Apr 2007 | - | -$526.50 K(-34.5%) | -$2.16 M(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2007 | - | -$804.20 K(+128.7%) | -$2.26 M(+21.4%) |
| Oct 2006 | -$1.86 M(+7.8%) | -$351.60 K(-26.0%) | -$1.86 M(-3.8%) |
| July 2006 | - | -$475.10 K(-24.1%) | -$1.93 M(+2.1%) |
| Apr 2006 | - | -$625.70 K(+54.2%) | -$1.89 M(+13.8%) |
| Jan 2006 | - | -$405.80 K(-4.6%) | -$1.66 M(-3.6%) |
| Oct 2005 | -$1.72 M(+41.2%) | -$425.30 K(-2.4%) | -$1.72 M(+1.4%) |
| July 2005 | - | -$435.70 K(+10.1%) | -$1.70 M(+3.3%) |
| Apr 2005 | - | -$395.80 K(-15.3%) | -$1.65 M(+15.7%) |
| Jan 2005 | - | -$467.30 K(+16.5%) | -$1.42 M(+16.5%) |
| Oct 2004 | -$1.22 M(+27.2%) | -$401.20 K(+5.4%) | -$1.22 M(+5.0%) |
| July 2004 | - | -$380.70 K(+120.6%) | -$1.16 M(+34.9%) |
| Apr 2004 | - | -$172.60 K(-35.2%) | -$861.60 K(-8.3%) |
| Jan 2004 | - | -$266.20 K(-22.4%) | -$939.70 K(-2.1%) |
| Oct 2003 | -$959.50 K(+104.1%) | -$343.10 K(+330.5%) | -$959.60 K(-9.8%) |
| July 2003 | - | -$79.70 K(-68.2%) | -$1.06 M(-42.0%) |
| Apr 2003 | - | -$250.70 K(-12.4%) | -$1.83 M(-36.7%) |
| Jan 2003 | - | -$286.10 K(-36.0%) | -$2.89 M(+515.8%) |
| Oct 2002 | -$470.00 K(-35.9%) | -$446.90 K(-47.3%) | -$470.00 K(-34.9%) |
| July 2002 | - | -$848.30 K(-35.4%) | -$721.80 K(-138.7%) |
| Apr 2002 | - | -$1.31 M(-161.4%) | $1.87 M(-23.2%) |
| Jan 2002 | - | $2.14 M(-406.0%) | $2.43 M(-431.3%) |
| Oct 2001 | -$733.80 K(-84.9%) | -$698.70 K(-140.2%) | -$733.90 K(-51.8%) |
| July 2001 | - | $1.74 M(-332.7%) | -$1.52 M(-65.6%) |
| Apr 2001 | - | -$747.70 K(-27.2%) | -$4.43 M(-9.6%) |
| Jan 2001 | - | -$1.03 M(-30.9%) | -$4.90 M(+0.6%) |
| Oct 2000 | -$4.87 M(-20.1%) | -$1.49 M(+27.3%) | -$4.87 M(-4.2%) |
| July 2000 | - | -$1.17 M(-4.0%) | -$5.08 M(-11.1%) |
| Apr 2000 | - | -$1.22 M(+21.6%) | -$5.72 M(+0.3%) |
| Jan 2000 | - | -$1.00 M(-41.2%) | -$5.70 M(-6.6%) |
| Oct 1999 | -$6.10 M(-22.8%) | -$1.70 M(-5.6%) | -$6.10 M(0.0%) |
| July 1999 | - | -$1.80 M(+50.0%) | -$6.10 M(0.0%) |
| Apr 1999 | - | -$1.20 M(-14.3%) | -$6.10 M(-14.1%) |
| Jan 1999 | - | -$1.40 M(-17.6%) | -$7.10 M(-10.1%) |
| Oct 1998 | -$7.90 M(-25.5%) | -$1.70 M(-5.6%) | -$7.90 M(-11.2%) |
| July 1998 | - | -$1.80 M(-18.2%) | -$8.90 M(-10.1%) |
| Apr 1998 | - | -$2.20 M(0.0%) | -$9.90 M(-1.0%) |
| Jan 1998 | - | -$2.20 M(-18.5%) | -$10.00 M(-5.7%) |
| Oct 1997 | -$10.60 M(+130.4%) | -$2.70 M(-3.6%) | -$10.60 M(+14.0%) |
| July 1997 | - | -$2.80 M(+21.7%) | -$9.30 M(+19.2%) |
| Apr 1997 | - | -$2.30 M(-17.9%) | -$7.80 M(+16.4%) |
| Jan 1997 | - | -$2.80 M(+100.0%) | -$6.70 M(+45.7%) |
| Oct 1996 | -$4.60 M(+53.3%) | -$1.40 M(+7.7%) | -$4.60 M(+12.2%) |
| July 1996 | - | -$1.30 M(+8.3%) | -$4.10 M(+13.9%) |
| Apr 1996 | - | -$1.20 M(+71.4%) | -$3.60 M(+20.0%) |
| Jan 1996 | - | -$700.00 K(-22.2%) | -$3.00 M(+3.4%) |
| Oct 1995 | -$3.00 M(-18.9%) | -$900.00 K(+12.5%) | -$2.90 M(+3.6%) |
| July 1995 | - | -$800.00 K(+33.3%) | -$2.80 M(-3.4%) |
| Apr 1995 | - | -$600.00 K(0.0%) | -$2.90 M(-9.4%) |
| Jan 1995 | - | -$600.00 K(-25.0%) | -$3.20 M(-11.1%) |
| Oct 1994 | -$3.70 M(+37.0%) | -$800.00 K(-11.1%) | -$3.60 M(+2.9%) |
| July 1994 | - | -$900.00 K(0.0%) | -$3.50 M(+6.1%) |
| Apr 1994 | - | -$900.00 K(-10.0%) | -$3.30 M(+10.0%) |
| Jan 1994 | - | -$1.00 M(+42.9%) | -$3.00 M(+15.4%) |
| Oct 1993 | -$2.70 M(+50.0%) | -$700.00 K(0.0%) | -$2.60 M(+8.3%) |
| July 1993 | - | -$700.00 K(+16.7%) | -$2.40 M(+14.3%) |
| Apr 1993 | - | -$600.00 K(0.0%) | -$2.10 M(+10.5%) |
| Jan 1993 | - | -$600.00 K(+20.0%) | -$1.90 M(+11.8%) |
| Oct 1992 | -$1.80 M(+50.0%) | -$500.00 K(+25.0%) | -$1.70 M(+13.3%) |
| July 1992 | - | -$400.00 K(0.0%) | -$1.50 M(+7.1%) |
| Apr 1992 | - | -$400.00 K(0.0%) | -$1.40 M(+7.7%) |
| Jan 1992 | - | -$400.00 K(+33.3%) | -$1.30 M(+8.3%) |
| Oct 1991 | -$1.20 M(+9.1%) | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| July 1991 | - | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Apr 1991 | - | -$300.00 K(0.0%) | -$1.20 M(+9.1%) |
| Jan 1991 | - | -$300.00 K(0.0%) | -$1.10 M(0.0%) |
| Oct 1990 | -$1.10 M(+10.0%) | -$300.00 K(0.0%) | -$1.10 M(+37.5%) |
| July 1990 | - | -$300.00 K(+50.0%) | -$800.00 K(+60.0%) |
| Apr 1990 | - | -$200.00 K(-33.3%) | -$500.00 K(+66.7%) |
| Jan 1990 | - | -$300.00 K | -$300.00 K |
| Oct 1989 | -$1.00 M | - | - |
FAQ
- What is Anixa Biosciences annual free cash flow?
- What is the all time high annual FCF for Anixa Biosciences?
- What is Anixa Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Anixa Biosciences?
- What is Anixa Biosciences quarterly FCF year-on-year change?
- What is Anixa Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Anixa Biosciences?
- What is Anixa Biosciences TTM FCF year-on-year change?
What is Anixa Biosciences annual free cash flow?
The current annual FCF of ANIX is -$6.21 M
What is the all time high annual FCF for Anixa Biosciences?
Anixa Biosciences all-time high annual free cash flow is $1.31 M
What is Anixa Biosciences quarterly free cash flow?
The current quarterly FCF of ANIX is -$2.64 M
What is the all time high quarterly FCF for Anixa Biosciences?
Anixa Biosciences all-time high quarterly free cash flow is $4.60 M
What is Anixa Biosciences quarterly FCF year-on-year change?
Over the past year, ANIX quarterly free cash flow has changed by -$674.00 K (-34.23%)
What is Anixa Biosciences TTM free cash flow?
The current TTM FCF of ANIX is -$8.38 M
What is the all time high TTM FCF for Anixa Biosciences?
Anixa Biosciences all-time high TTM free cash flow is $3.39 M
What is Anixa Biosciences TTM FCF year-on-year change?
Over the past year, ANIX TTM free cash flow has changed by -$2.17 M (-34.92%)